Dr TEOH Yuen Chun Jeremy    
張源津

Associate Professor
MBBS, FRCSEd (Urol), FCSHK, FHKAM (Surgery)

Urology
(852) 3505 2625 / Appointment 3505 2954
jeremyteohadd this for spam@add this for spamsurgery.cuhk.edu.hk
@jteoh_hk
H-5184-2016
0000-0002-9361-2342

Biography

Dr Jeremy Teoh is currently the Assistant Dean (External Affairs) and Associate Professor of the Faculty of medicine, The Chinese University of Hong Kong. He has primary interests in bladder cancer and prostate cancer. For bladder cancer, he is leading a multi-centre randomized controlled trial on transurethral en bloc resection of bladder tumour. He has also developed a global consensus statement to standardize the en bloc resection approach. He is currently studying the urinary biomarkers, tumour heterogeneity and molecular classification of bladder cancer. For prostate cancer, he has published extensively on the adverse events related to androgen deprivation therapy. He has also helped conduct a clinical trial on the use of the da Vinci Single-Port Surgical System in radical prostatectomy.

Jeremy was awarded the Ten Outstanding Young Persons Award (Hong Kong) and the SIU-Innovators Award in 2021. He has received numerous research grants with a total funding of more than HKD 80 million. He has published more than 200 articles in peer-reviewed journals such as Nature Reviews Urology, European Urology, Journal of Urology and Annals of Surgery. He is an editorial board member for a number of prominent journals, and he has been serving as a member for several advisory boards for prostate cancer and bladder cancer. Jeremy was the Chairperson of the Younger Fellows Chapter of the College of Surgeons of Hong Kong (2019-2021), the Chair of the Young Fellows Chapter of the Hong Kong Academy of Medicine (2021-2022), and he has been the Director of the Lions Kidney Educational Centre & Research Foundation since 2016. He is also the founder of the UroSoMe (Urology Social Media) working group and he believes that social media plays an important role in the modern era of medicine.

Research Interests

• Urinary biomarkers for bladder cancer
• Tumour heterogeneity and molecular classification of bladder cancer
• Transurethral en bloc resection of bladder tumour
• Androgen deprivation therapy for prostate cancer
• Advanced robotic surgery for urological cancers

Additional Information

• Director of the Urology Centre, CUHK Medical Centre
• Director of the Lions Kidney Educational Centre & Research Foundation
• Member of the Office of Global Engagement, Faculty of Medicine, The Chinese University of Hong Kong
• Member of the Committee on Promotion of Organ Donation, HKSAR
• Council member of the Hong Kong Society of Transplantation
• Chairperson of the Younger Fellows Chapter of the College of Surgeons of Hong Kong (2019-2021)
• Chair of the Young Fellows Chapter, Hong Kong Academy of Medicine (2021-2022)
• Faculty of the Asian Urological Surgery Training & Education Group
• Founder of the UroSoMe (Urology Social Media) working group
• Consulting editor for European Urology
• Associate editor for Andrologia
• Social media editor for the SIU journal
• Social media editor for the Hong Kong Medical Journal
• Editor for Prostate Cancer and Prostatic Diseases
• Editor for PLOS One

Selected Publications

1. Teoh JY, MacLennan S, Chan VW, Miki J, Lee HY, Chiong E, et al. An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting. Eur Urol 2020. (Impact factor: 24.267)
2. Teoh JY, Ong WLK, Gonzalez-Padilla D, Castellani D, Dubin JM, Esperto F, et al. A Global Survey on the Impact of COVID-19 on Urological Services. Eur Urol 2020;78:265-75. (Impact factor: 24.267)
3. Teoh JY, Huang J, Ko WY, Lok V, Choi P, Ng CF, et al. Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita. Eur Urol 2020;78:893-906. (Impact factor: 24.267)
4. Teoh JY, Castellani D, Mercader C, Sierra A, Heldwein FL, Chan EO, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol. 2021;80(4):442-9. (Impact factor: 24.267)
5. Rodriguez Socarrás M, Loeb S, Teoh JY, Ribal MJ, Bloemberg J, et al. Telemedicine and Smart Working: Recommendations of the European Association of Urology. Eur Urol 2020;78:812-9. (Impact factor: 24.267)
6. Chiu PK, Ng CF, Semjonow A, Zhu Y, Vincendeau S, Houlgatte A, Lazzeri M, Guazzoni G, Stephan C, Haese A, Bruijne I, Teoh JY, et al. A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings. Eur Urol 2019; 75(4):558-561. (Impact factor: 24.267)
7. Wang G, Choi KS, Teoh JY, Lu J. Deep Cross-Output Knowledge Transfer Using Stacked-Structure Least-Squares Support Vector Machines. IEEE Trans Cybern. 2022;52(5):3207-20. (Impact factor: 19.118)
8. Teoh JY, Kamat AM, Black PC, Grivas P, Shariat SF, Babjuk M. Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective. Nat Rev Urol. 2022;19(5):280-94. (Impact factor 16.430)
9. Teoh JY, Yip TC, Lui GC, Wong VW, Chow VC, Ho TH, et al. Risks of AKI and Major Adverse Clinical Outcomes in Patients with Severe Acute Respiratory Syndrome or Coronavirus Disease 2019. J Am Soc Nephrol. 2021;32(4):961-71. (Impact factor: 14.978)
10. Tan YQ, Wang Z, Yap QV, Chan YH, Ho RC, Hamid A, Landaluce-Olavarria A, Pellino G, Gauhar V, Chand M, Wroclawski ML, Hameed BMZ, Ling SK, Sengupta S, Gallo G, Chiu PK, Tanidir Y, Tallada MPV, Garcia BN, Colleoni R, Abiddin ZAZ, Campi R, Esperto F, Carrion D, Elterman D, Chung ASJ, Ng ACF, Moschini M, Rivas JG, Mayol J, Teoh JY*, Chiong E*. Psychological Health of Surgeons in a Time of COVID-19: A Global Survey. Ann Surg. 2021. *Co-corresponding authors. (Impact factor 13.787)

The full list of publications can be accessed here.